StartUPDATES: New Developments from Healthcare Startups
Check out news from Equiva, First In Venture Studio, and Parallel Bio.
Check out news from Equiva, First In Venture Studio, and Parallel Bio.
Check out new developments from Carrum Health, Equiva, imaware, Elo, Paige, Gozio Health and WELL Health.
Check out new developments from Carrum Health, Equiva, Carefeed, Brain Check, and Atropos Health.
Check out news from Equiva, Canvas Medical, Particle Health, Fold Health, and Nucleus Genomics.
Check out news from Equiva, Vida Health, Canaery, and DocPanel.
Check out new developments from Equiva, SonALAsense, Sensible Care, and more.
Check out news from Opala, Equiva, Sling Therapeutics, Quil, and Third Rock Ventures.
Check out news from Equiva, PrecisionGx, Wavemaker Three-Sixty Health, Jasper Health, and Anagenex.
Check out news from Memory Health, Equiva, KAID Health, Tegria, and Japa Health.
Check out news from Equiva, Evernow, StationMD, Nurse 1-1, and more.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Check out news from Equiva, Healthmine, Recora, and Antidote Health.
Read about news from Element Science, Healthmine, Equiva, UniDoc Health Corp., and House RX.
Read about news from Equiva, Healthmine, Prenosis, 9am.health, and Socially Determined.
Read about news from Equiva, Doceree, Verana Health and XR Health.
Check out news from Equiva, Minded, Rightway and more.